DHA sttr phase II - automated spectrometry system for ptsd biomarkers

Ended Definitive Contract Awarded Last action

Contract number
HT942524C0006
Awardee
Awarding agency
Obligated
$1,149,995

Award facts

Opportunity
  • HQ003420RBDST Solicitation number
Contract value 100% obligated
$1,149,995.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Charlottesville, VA, USA
Research
STTR Phase II

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $0
Funding Only Action P00001 $574,996
Original award $574,999

About this award

The Defense Health Agency awarded a $1.15M firm fixed-price Definitive Contract to Luna Labs USA LLC, a small business set-aside, for development of an Automated Spectrometry System for PTSD Biomarkers under the Small Business Technology Transfer (STTR) Phase II program. This award, announced November 27, 2023, represents Phase II funding for what appears to be a follow-on effort from successful Phase I research. Luna Labs USA LLC, headquartered in Charlottesville, Virginia, will perform the work at its primary location and is a subsidiary of Luna Innovations Incorporated, a manufacturer specializing in advanced fiber optic sensing and measurement systems. The contract extends through March 26, 2026, supporting the Defense Health Agency's mission to develop innovative medical diagnostic technologies for military and veteran healthcare applications.

The STTR Phase II program is designed to help small businesses and research institutions commercialize promising technologies developed in Phase I by providing substantial funding for prototype development and testing. Under this award, Luna Labs will advance spectrometry-based biomarker detection capabilities intended to support clinical assessment and diagnosis of post-traumatic stress disorder, a significant health concern affecting service members and veterans. This contract aligns with Luna Labs' demonstrated expertise in developing advanced sensing systems and medical diagnostic technologies through prior SBIR/STTR engagements and reflects the company's growing portfolio of defense and healthcare-focused R&D projects within the federal innovation ecosystem.

Subawards

Subcontractor Amount Awarded
LC Acquisition LLC DHA STTR PHASE II - AUTOMATED SPECTROMETRY SYSTEM FOR PTSD BIOMARKERS Custom UI development for HPLC device. $90,000
Rowan University DHA STTR PHASE II - AUTOMATED SPECTROMETRY SYSTEM FOR PTSD BIOMARKERS Method development on a portable HPLC and evalution of usability of sample prep device… $356,991

Quick answers

Who was awarded contract HT942524C0006?

HT942524C0006 was awarded to Luna Labs USA LLC by Defense Health Agency (Department of Defense) on November 19, 2023.

How much is contract HT942524C0006 worth?

The government has obligated $1,149,995 on HT942524C0006.

Was contract HT942524C0006 competed?

The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award